Vivacy

Founded in 2007 by a French entrepreneur, Vivacy pioneered the development of injectable dermal fillers based on hyaluronic acid. Naturally present in the human body, this compound generates no immune response. These injectable dermal fillers can only be administered by qualified healthcare professionals, with each application lasting between six and nine months.

Vivacy's patent-protected injectable products are Class III medical devices requiring approval from medical authorities. They stand out from the competition thanks to their ease of injection and superior quality. Vivacy also offers healthcare professionals training in the use of its products. This enables the dermal fillers marketed by Vivacy to boast a very high patient retention rate (>90%), making Vivacy a solid and resilient company.

Vivacy continues to attract new patients from its traditional target clientele, but also from new populations (such as men) and new regions (Middle East, China).

‍